Csam Health Group AS
F:6Q1
Csam Health Group AS
F:6Q1
Price:
3.63
EUR
-3.46%
Market Cap:
€73.5m
Relative Value
There is not enough data to reliably calculate the relative value of 6Q1.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
6Q1
Relative Value
Base Case
Not Available
Multiples Across Competitors
6Q1 Competitors Multiples
Csam Health Group AS Competitors
Csam Health Group AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
|
Csam Health Group AS
F:6Q1
|
830.7m EUR | 2.1 | -7.8 | 65.5 | -14.8 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | 21.9 | 43.2 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
30.2B USD | 9.8 | 35 | 25.3 | 26.4 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
16.4B AUD | 74.5 | 142.6 | 98.2 | 98.2 | |
| JP |
|
M3 Inc
TSE:2413
|
1.2T JPY | 3.6 | 25.7 | 12.6 | 15.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
6.3B USD | 10 | 24.6 | 20.7 | 21.6 | |
| SE |
|
Sectra AB
STO:SECT B
|
39.9B SEK | 17.8 | 61.8 | -121.6 | -121.6 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.2B USD | 4 | 37.7 | 13.1 | 20.5 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
24.5B CNY | 11.3 | -79.4 | -156.9 | -156.9 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
288.2B INR | 10.9 | 59.6 | 36.6 | 42.7 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 | 267.9 | 4 290.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
